| Ytd | -11.32% | |
| 1y | -3.15% |
| Open | 0.98 | Prev Close | 0.96 | Low | 0.97 | High | 0.99 | Mkt Cap | 184.40M |
| Vol | 451.20K | Avg Vol | 1.46M | EPS | -0.37 | P/E | -2.61 | Forward P/E | -1.12 |
| Beta | 1.08 | Short Ratio | 0.80 | Inst. Own | 4.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 0.99 | 200-d Avg | 1.13 | 1yr Est | 3.50 |
Concert's policy recognizes EsoGuard ® as the only esophageal precancer test meeting its coverage cr
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Compa
Conference Call and Webcast at 8:30 AM ET NEW YORK, July 31, 2026 /PRNewswire/ -- PAVmed Inc. (Nasd
Conference Call and Webcast at 8:30 AM ET NEW YORK, July 30, 2026 /PRNewswire/ -- Lucid Diagnostics
Lucid Diagnostics offers asymmetric upside, with Medicare reimbursement as a near-term inflection po
Lucid Diagnostics Inc. (LUCD) Shareholder/Analyst Call Prepared Remarks Transcript
Veris Health progressed commercial expansion and advanced implantable physiological monitor developm
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript
Lucid Diagnostics NASDAQ: LUCD reported first-quarter 2026 EsoGuard test volume above its pre-Medica
Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.07 per share versus the Zacks Con
Processed 3,177 EsoGuard ® tests and recognized 1Q26 revenue of $1.3 million, ending quarter with $4
Lucid Diagnostics (LUCD) doesn't possess the right combination of the two key ingredients for a like
Conference Call and Webcast at 8:30 AM ET NEW YORK, May 1, 2026 /PRNewswire/ -- PAVmed Inc. (Nasdaq
Conference Call and Webcast at 8:30 AM ET NEW YORK, April 30, 2026 /PRNewswire/ -- Lucid Diagnostic
NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Com
NEW YORK, April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Com
Shares of Lucid Diagnostics Inc. (NASDAQ: LUCD - Get Free Report) have received an average recommend
Top analysts change outlook on top names, like AA, SSSS, TXN, HQY, LUCD, RPM, PAR, ASRT. Morgan Stan
NEW YORK, April 9, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Com
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future
PAVmed strengthened its capital structure and relaunched its medical device portfolio under new lead
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings f
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly
During Monday's session, 402 companies made new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Tuesday, 507 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn
On Friday, 1043 companies hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched